PCRX earnings: a positive outcome, +5.9%

On August 2, 2018, Pacira BioSciences, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.9% in the window around the event. It had already run +21.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.